PER 1.23% 8.0¢ percheron therapeutics limited

fda gives thumbs up to antisense !!

  1. 9,102 Posts.
    lightbulb Created with Sketch. 386
    FDA

    "announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for KYNAMRO(TM) (mipomersen sodium) for the treatment of patients with homozygous familial hypercholesterolemia (HoFH). The NDA filing with the FDA triggers a $25 million milestone payment to Isis from Genzyme."

    http://www.marketwatch.com/story/genzyme-and-isis-announce-filing-of-us-nda-for-kynamrotm-mipomersen-sodium-in-homozygous-familial-hypercholesterolemia-2012-05-29

    Big tick to Antisense !

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.